These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 14969166)

  • 21. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of hormonal contraceptives in an institutional setting: reasons for use, consent and safety in women with psychiatric and intellectual disabilities.
    Egan TM; Siegert RJ; Fairley NA
    N Z Med J; 1993 Aug; 106(961):338-41. PubMed ID: 8341476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statement on injectable contraception. Revised.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1992 Dec; 26(6):4-6. PubMed ID: 12346921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DMPA for contraception discussed by international forum of experts.
    Netw Int Fertil Res Program; 1979 Oct; ():2-3. PubMed ID: 12261372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injectable contraception. New and existing options.
    Kaunitz AM
    Obstet Gynecol Clin North Am; 2000 Dec; 27(4):741-80. PubMed ID: 11091987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
    Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
    Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting injectable contraception with depot medroxyprogesterone acetate.
    Kaunitz AM
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of injectable contraceptive users in a low-income population in Texas.
    Sangi-Haghpeykar H; Poindexter AN; Moseley DC; Bateman L; Reid ED
    Fam Plann Perspect; 1995; 27(5):208-11, 225. PubMed ID: 9104608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facts about injectable contraception.
    Contracept Rep; 1994 Mar; 5(1):1-2. PubMed ID: 12287737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Millions of couples to have choice of injectable contraceptive.
    Integration; 1996; (47):41. PubMed ID: 12347310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health.
    Guilbert ER; Brown JP; Kaunitz AM; Wagner MS; Bérubé J; Charbonneau L; Francoeur D; Gilbert A; Gilbert F; Roy G; Senikas V; Jacob R; Morin R
    Contraception; 2009 Mar; 79(3):167-77. PubMed ID: 19185668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M; El-Mallah SY; Seoudi S; Hassan M; Mohsen IA
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
    JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
    Balogun OR; Raji HO
    Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer.
    Entre Nous Cph Den; 1996 May; (32):11. PubMed ID: 12222270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current options for injectable contraception in the United States.
    Kaunitz AM
    Semin Reprod Med; 2001 Dec; 19(4):331-7. PubMed ID: 11727175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts regarding use of DMPA.
    Kaunitz AM
    J Reprod Med; 2002 Sep; 47(9 Suppl):785-9. PubMed ID: 12380407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.